Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Treatment of Gastric and Duodenal Ulcers”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT06552624
What this trial is testing

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Who this might be right for
HeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers
Valenta Pharm JSC 40
Large-scale testing (Phase 3)Ended earlyNCT00557921
What this trial is testing

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Cogentus Pharmaceuticals 5,000
Not applicableStudy completedNCT04724291
What this trial is testing

MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)

Who this might be right for
Abdominal PainGastritisGastric Ulcer+1 more
George Washington University 43
Not applicableUnknownNCT06098742
What this trial is testing

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Who this might be right for
HeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers
Valenta Pharm JSC 50
Post-approval studies (Phase 4)Looking for participantsNCT04416581
What this trial is testing

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndrome+1 more
Duk-Woo Park, MD 3,320